BrightSpring Health Services, Inc. (BTSG) AI Stock Analysis

BrightSpring Health Services, Inc. offers a comprehensive home and community-based healthcare services platform across the United States. The platform delivers a wide range of pharmacy and provider services, encompassing clinical and supportive care tailored to the needs of Medicare, Medicaid, and insured populations. It serves patients through a network of clinical providers and pharmacists in home and community settings. Originally known as Phoenix Parent Holdings Inc., the company rebranded in May 2021. Founded in 1974 and headquartered in Louisville, Kentucky, BrightSpring focuses on integrated care solutions across its expanding services.

BrightSpring grew revenue from $6.70B in FY2021 to $7.72B in FY2022, $8.83B in FY2023, $11.27B in FY2024, and $12.91B in FY2025, reflecting a 5-year revenue CAGR of 18.3%. Net income shifted from $49.8M in FY2021 to net losses of -$53.9M in FY2022, -$154.6M in FY2023, and -$18.1M in FY2024, before rebounding to $190.7M in FY2025. Gross margin declined from 18.6% in FY2021 to 11.8% in FY2025, while operating margin sat at 2.3% in FY2025. For the trailing twelve months, revenue was $14.37B with a net profit margin of 2.5%. In the latest quarter ended June 30, 2026, quarterly revenue grew 23.0% and quarterly earnings surged 196.6% year-over-year.

As of June 30, 2026, BrightSpring held $550.4M in cash and short-term investments against total debt of $2.39B, resulting in net debt of $1.84B. The current ratio was 1.59, and debt-to-equity stood at 1.17 against shareholders' equity of $2.05B. In FY2025, operating cash flow reached $490.2M and free cash flow stood at $394.7M. Capital allocation in FY2025 included capital expenditures of $95.5M and share buybacks of $43.2M.

BTSG traded at a trailing P/E of 53.9x and a forward P/E of 22.2x, compared to the median of its US-listed Healthcare peers of 24.6x trailing and 17.3x forward. Its enterprise value to EBITDA ratio was 21.2x, higher than the peer median of 12.0x. However, its price-to-sales multiple of 0.8x stood well below the peer median of 4.1x. Over the past year, BTSG delivered a return of 106.7%, outperforming the 16.8% return of the S&P 500 (SPY).

Wall Street coverage includes 15 StrongBuy ratings, 3 Buy ratings, and 0 Hold or Sell ratings. The mean price target is $78.94, representing a 29.7% upside relative to the last close of $60.87. For the fiscal year ending December 31, 2026, consensus estimates project EPS of $1.82 on revenue of $15.37B. The company recorded 4 EPS beats out of the last 4 quarters. The next earnings date is October 30, 2026.

This page is an AI-written research summary of BrightSpring Health Services, Inc. (BTSG). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: BTSG income statement, BTSG balance sheet, BTSG key metrics, BTSG analyst forecast, BTSG chart. See the BTSG stock overview for the latest quote and news.